A Phase II Safety and Efficacy Study of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Patients With Metastatic Urothelial Cancer
Titel:
A Phase II Safety and Efficacy Study of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Patients With Metastatic Urothelial Cancer
Auteur:
Pili, Roberto Qin, Rui Flynn, P.J. Picus, Joel Millward, Michael Ho, Wing Ming Pitot, Henry Tan, Winston Miles, Kiersten M. Erlichman, Charles Vaishampayan, Ulka